USE OF PRENATAL GLUCOCORTICOID THERAPY TO PREVENT RESPIRATORY-DISTRESS SYNDROME - SUPPORTING VIEW

被引：62

作者：

BALLARD, RA

BALLARD, PL

机构：

[1] UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA

[2] UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SPECIALIZED CTR RES PULM DIS, SAN FRANCISCO, CA 94143 USA

[3] MT ZION HOSP & MED CTR, DEPT PEDIAT, SAN FRANCISCO, CA 94120 USA

来源：

AMERICAN JOURNAL OF DISEASES OF CHILDREN | 1976年 / 130卷 / 09期

关键词：

D O I：

10.1001/archpedi.1976.02120100072011

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

The clinical experience to date with prenatal betamethasone indicates that this therapy is effective in preventing RDS [respiratory distress syndrome] in many prematurely born infants. Except for a possible increase of fetal deaths in pregnancies complicated by severe preeclamptic toxemia, this therapy is now known to be associated with adverse effects for either mothers or infants.

引用

页码：982 / 987

页数：6

共 46 条

[21]

FITZHARDINGE PM, 1974, PEDIATRICS, V53, P877

[22] VARIATIONS IN LEVELS OF CYTOPLASMIC GLUCOCORTICOID RECEPTORS IN LUNGS OF VARIOUS SPECIES AT DIFFERENT DEVELOPMENTAL STAGES [J].